Old Web
English
Sign In
Acemap
>
authorDetail
>
Xu Wang
Xu Wang
Boehringer Ingelheim
Empagliflozin
Cardiology
Relative risk
Internal medicine
Type 2 diabetes
1
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China.
2021
Cost Effectiveness and Resource Allocation
M. Ramos
Peng Men
Xu Wang
Anastasia Ustyugova
Mark Lamotte
Show All
Source
Cite
Save
Citations (0)
1